Unlock instant, AI-driven research and patent intelligence for your innovation.

Oxaspirophosphine-oxazoline ligand and preparation method and application thereof

An oxaspiro and oxazoline technology is applied in the field of oxaspirophosphine-oxazoline ligands and their preparation, and can solve the problems of long reaction steps, low product ee value, low total yield and the like

Active Publication Date: 2022-07-29
SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] This route has long reaction steps, low overall yield, long time consumption, and low ee value of the product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oxaspirophosphine-oxazoline ligand and preparation method and application thereof
  • Oxaspirophosphine-oxazoline ligand and preparation method and application thereof
  • Oxaspirophosphine-oxazoline ligand and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0037] A second aspect of the present invention provides a method for preparing an oxaspirophosphine-oxazoline ligand, which comprises the following steps,

[0038] (i) the compound represented by the formula (1) is prepared in a CO atmosphere under the action of a metal catalyst, a ligand and a base to obtain the compound represented by the formula (2),

[0039] (ii) the compound represented by the formula (2) and the compound represented by the formula (7) are subjected to a cyclization reaction to obtain the oxaspirophosphine-oxazoline ligand represented by the formula (3),

[0040]

[0041] In an embodiment of the method for preparing an oxaspirophosphine-oxazoline ligand of the present invention, in the step (1), the metal catalyst is palladium acetate.

[0042] In another embodiment of the method for preparing an oxaspirophosphine-oxazoline ligand of the present invention, in the step (1), the ligand is 1,3-bis(diphenylphosphino)propane.

[0043] In another embodimen...

Embodiment 1

[0084] Example 1 compound (S a )-2b preparation

[0085]

[0086] In an argon atmosphere, compound (S a )-1b (3.90 g, 7.0 mmol), methanol (42 mL), palladium acetate (259 mg, 1.16 mmol), dppp (478 mg, 1.46 mmol), dimethylsulfoxide (60 mL) and triethylamine (11.6 mL). The reaction mixture was reacted under a carbon monoxide atmosphere at 70°C until the reaction was complete. It was cooled to room temperature, extracted with ethyl acetate three times, and then the solvent in the mixture was removed under reduced pressure, and the crude product was directly hydrolyzed in the presence of potassium hydroxide. Finally, the compound (S) can be obtained by column chromatography a )-2b (2.02 g, yield 64%);

[0087] [α] 25 D =-32.00(c=0.5,acetone);

[0088] 1 H NMR (400MHz, Chloroform-d): δ 7.36-7.17 (m, 4H), 7.17-7.00 (m, 2H), 6.94 (d, J=6.5Hz, 1H), 6.76 (t, J=8.5Hz) , 4H), 6.54(s, 1H), 4.98(d, J=8.4Hz, 1H), 4.74(d, J=8.3Hz, 2H), 4.62(d, J=8.5Hz, 1H), 1.15(s , 18H), 1.13(...

Embodiment 2

[0090] Example 2 compound (R a )-2a preparation

[0091]

[0092] According to the method described in Example 1, compound (R a )-1a was prepared to obtain compound (R a )-2a, whose detection data is as follows:

[0093] [α] 25 D =+23.40(c=0.5, methanol);

[0094] 1 H NMR (400MHz, Chloroform-d): δ 7.32-7.22 (m, 4H), 7.22-7.14 (m, 3H), 7.13-7.01 (m, 4H), 6.90-6.79 (m, 2H), 6.67 ( m, 1H), 6.29 (dd, J=7.9, 0.8Hz, 1H), 5.73 (dd, J=8.0, 0.8Hz, 1H), 5.01 (dd, J=9.2, 2.6Hz, 1H), 4.67 (d , J=9.3Hz, 1H), 4.62 (dd, J=9.2, 1.3Hz, 1H), 4.53 (d, J=9.4Hz, 1H). 13 C NMR (101MHz, Chloroform-d): δ 161.29, 161.27, 160.25, 160.2, 143.5, 137.1, 137.0, 135.9, 135.7, 135.1, 135.0, 134.1, 133.9, 133.3, 133.1, 132.5, 1299.2, 130 128.7, 128.29, 128.25, 128.2, 128.1, 128.0, 127.8, 127.7, 110.9, 108.8, 83.3, 80.7, 56.1. 31 P NMR (162MHz, Chloroform-d): δ-22.55;

[0095] HRMS(ESI)calcd.for C 28 H 20 O 4 P[M-H] - :451.1105.Found:451.1104.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oxaspirophosphine-oxazoline ligand and a preparation method and application thereof. The oxaspirophosphine-oxazoline ligand is a compound represented by formula (3) or a compound represented by formula (3). The stereoisomer of the ligand and the metal iridium catalyst can be complexed to form a catalyst complex with good catalytic performance, which can be used for asymmetric reduction reactions, especially the reduction reactions of lorcaserin intermediates and their analogs,

Description

technical field [0001] The invention relates to the technical field of catalytic reaction ligands, in particular to an oxaspirophosphine-oxazoline ligand, a preparation method thereof, and an application in asymmetric synthesis of lorcaserin. Background technique [0002] Phosphine-oxazoline ligands are an advantageous ligand with the characteristics of both phosphine ligands and nitrogen ligands, and can be used in a variety of asymmetric catalytic reactions (Li, M.-L.; Yang, S.; Su, X.-C.; Wu, H.-L.; Yang, L.-L.; Zhu, S.-F.; Zhou, Q.-L.J.Am.Chem.Soc.2017, 139, 541; A.; Diesen, J.S.; Chapman, C.J.; Andersson, P.G Org. Lett. 2004, 6, 3825). With the development of asymmetric science, more and more phosphine-oxazoline ligands have been developed, and their application in the synthesis of marketed drugs and / or their analogs can lead to simpler process routes and lower drug costs . [0003] Lorcaserin hydrochloride (Lorcaserin), a drug developed by Arena Pharmaceutical Compa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F9/6561B01J31/24C07D223/16C07C233/11C07C231/12
CPCC07F9/6561B01J31/2404C07D223/16C07C231/12C07B2200/07B01J2531/827B01J2531/0238B01J2231/645C07C2531/24C07C233/11
Inventor 叶祥宇梁志钦郑龙生陈根强张绪穆
Owner SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA